Skip to main content
Stephen Huhn, MD, Research, San Diego, CA

StephenL.HuhnMD

Research San Diego, CA

Chief Medical Officer and Senior Vice President Clinical Development PIpeline Therapeutics

Dr. Huhn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Huhn's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandResidency, Neurological Surgery, 1988 - 1993
  • University of Maryland Medical Center Midtown Campus
    University of Maryland Medical Center Midtown CampusInternship, Transitional Year, 1987 - 1988
  • University of Arizona College of Medicine
    University of Arizona College of MedicineClass of 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1993 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Fellow American Academy of Pediatrics
  • Fellow (FACS) American College of Surgeons
  • Fellow (FAANS) American Association of Neurological Surgeons

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1b/2a Study of PIPE-307 in Patients with Relapsing-Remitting Multiple Sclerosis
    Pipeline Therapeutics Receives IND Clearance from FDA to Initiate Phase 1b/2a Study of PIPE-307 in Patients with Relapsing-Remitting Multiple SclerosisMarch 28th, 2022
  • Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple Sclerosis
    Pipeline Therapeutics Reports Positive Phase 1 Clinical Results for PIPE-307, a Neuroregenerative Therapeutic for the Treatment of Multiple SclerosisMarch 10th, 2022
  • Pipeline Testing PIPE-307 Remyelinating Compound in Healthy Volunteers
    Pipeline Testing PIPE-307 Remyelinating Compound in Healthy VolunteersMarch 9th, 2021
  • Join now to see all

Professional Memberships